Amgen (AMGN) Buildings (2009 - 2022)

Amgen (AMGN) has reported Buildings for 14 consecutive years, with $4.2 billion the latest figure, recorded in Q4 2022.

• In Q4 2022, Buildings rose 4.29% year-over-year to $4.2 billion; the TTM figure through Dec 2022 stood at $4.2 billion (up 4.29% YoY), while the FY2022 annual figure was $4.2 billion, up 4.29% from the prior year.
• Buildings came in at $4.2 billion for Q4 2022 at Amgen, up from $4.0 billion in the prior quarter.
• The five-year high for Buildings was $4.2 billion in Q4 2022, with the low at $3.6 billion in Q4 2018.
• Average Buildings over 5 years is $3.9 billion, with a median of $3.9 billion recorded in 2020.
• Across the five-year window, Buildings rose 2.66% in 2020 and grew 4.43% in 2021, its largest moves.
• Year by year, Buildings stood at $3.6 billion in 2018, then rose by 3.9% to $3.8 billion in 2019, then gained by 2.66% to $3.9 billion in 2020, then rose by 4.43% to $4.0 billion in 2021, then gained by 4.29% to $4.2 billion in 2022.
• According to Business Quant data, Buildings over the past three periods registered $4.2 billion, $4.0 billion, and $3.9 billion for Q4 2022, Q4 2021, and Q4 2020 respectively.